The Helsinki Virus (HelVi) Core is a service platform that provides generation of recombinant adeno-associated viral (rAAV) preps for academic and industrial customers in Finland as well as abroad. HelVi uses biosafety level I laboratory equipped with all necessary cell culture equipment such as laminar hoods, incubators, centrifuges and microscopes.
Contact persons: Andrey Anisimov, +3582941 25562, email@example.com; Tanja Laakkonen, +3582841 25563, firstname.lastname@example.org; Kari Alitalo, Core director, +3582941 25511, email@example.com
Location: Biomedicum Helsinki, 5th floor, Haartmaninkatu 8, Meilahti Campus
The research infrastructure is supported by University of Helsinki (HiLIFE and Research Programs Unit) and Biocenter Finland. The prices for University of Helsinki customers (VAT 0 %) are listed below. For the other customers, the VAT is 24%.
|Internal customers||908,54 €|
|BCF customers||1001,19 €|
|External academic customers||2059,77 €|
|External customers||2059,77 €|
HelVi has several ready AAV preps in storage, which can be mainly used as a negative control in vivo or in vitro. These ready AAV preps * (as listed in the Table below) can be sold in smaller amounts, reducing the price.
|Human Serum Albumin (HSA)||AAV9|
|Empty vector (no transgene)||AAV9|
|Fc-part of mouse IgG (mFC)||AAV9, AAV2||Control for Fc-fuced proteins|
|EGFP||AAV9, AAV2, AAV8, AAV6|
|Luciferaasi||AAV9, AAV2, AAV8|
|Cre recombinase||AAV9, AAV2, AAV8||Can be used to cut away loxP flanked DNA sequences|
* For other available AAV preps, not included in the Table, please, send e-mail or call.